Pneumococcal Vaccination for Asplenic Pediatric Patients
Introduction to Vaccination Schedule
- The Centers for Disease Control and Prevention recommends that asplenic children receive both PCV13 and PPSV23 vaccines in a sequential schedule, with PCV13 administered first followed by PPSV23 at least 8 weeks later, starting at age 2 years or older 1
Age-Specific PCV13 Dosing for Asplenic Children
- For infants 2-6 months, administer the standard 4-dose series at 2, 4, 6, and 12-15 months of age, with a minimum interval of 4 weeks between primary series doses and a booster dose at 12-15 months given at least 8 weeks after the third dose, as recommended by the Centers for Disease Control and Prevention 2
- For children 12-23 months who are previously unvaccinated, administer 2 doses of PCV13 with at least 8 weeks between doses, as recommended by the Centers for Disease Control and Prevention 2, 4
- For children 24-71 months with asplenia who are unvaccinated or received less than 3 doses before age 24 months, give 2 doses of PCV13 with at least 8 weeks between doses, as recommended by the Centers for Disease Control and Prevention 1, 4
PPSV23 Administration After PCV13
- The Centers for Disease Control and Prevention recommends that all asplenic children aged 2 years and older receive PPSV23 after completing their recommended PCV13 doses, with a minimum interval of 8 weeks between the most recent PCV13 dose and PPSV23 administration 1
- For children 24-71 months with asplenia who received less than 3 doses of PCV before age 24 months, complete the 2-dose PCV13 series first, then give PPSV23 at least 8 weeks later, as recommended by the Centers for Disease Control and Prevention 1
Special Circumstances
- For children with incomplete vaccination history, do not restart the series, simply continue from where the child left off, using the age-appropriate catch-up schedule based on current age and number of previous doses, as recommended by the Centers for Disease Control and Prevention 2, 4
Common Pitfalls to Avoid
- The Centers for Disease Control and Prevention recommends not giving PPSV23 before PCV13 in vaccine-naive asplenic children, as this can impair the subsequent response to PCV13, and not skipping the PPSV23 after completing PCV13, as it provides coverage for additional serotypes not included in PCV13 1